Citation Impact
Citing Papers
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
2005
Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity
1998
Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations
2009
Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture
2016
Current progress in development of hepatitis C virus vaccines
2013
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
2002
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
2003
Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly
2012
Specific Cleavage of Hepatitis C Virus RNA Genome by Human RNase P
2002
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
2012
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
2012
Assembly of infectious hepatitis C virus particles
2010
Cancer burden in the year 2000. The global picture
2001 Standout
Ordering S phase and M phase in the cell cycle
1994 StandoutNobel
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
p25rum1 orders S phase and mitosis by acting as an inhibitor of the p34cdc2 mitotic kinase
1995 StandoutNobel
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Structural Determinants That Target the Hepatitis C Virus Core Protein to Lipid Droplets
2006
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes
2011
Alternate Translation Occurs within the Core Coding Region of the Hepatitis C Viral Genome
2002
Molecular Determinants and Dynamics of Hepatitis C Virus Secretion
2012
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
2007
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment
2013
Interaction of hepatitis C virus proteins with host cell membranes and lipids
2002
Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor
2003
High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I
2005
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Host neutralizing responses and pathogenesis of hepatitis C virus infection†
2008
The ubiquitin-proteasome proteolytic pathway
1994 StandoutNobel
Interaction between hepatitis C virus proteins and host cell factors
2002 StandoutNobel
Hepatitis C Virus RNA Replication
2013
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
2004
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Cell entry of hepatitis C virus
2006
Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles
2010
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
2009
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets
2002
Mos and the cell cycle: the molecular basis of the transformed phenotype
1993
Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin
2008
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
2010
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI
2006
Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein
1998
Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
2010
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
2006
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Trafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly
2011
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
2010
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Mechanisms and significance of liver steatosis in hepatitis C virus infection
2006
Virion Assembly and Release
2013
The Lipid Droplet Binding Domain of Hepatitis C Virus Core Protein Is a Major Determinant for Efficient Virus Assembly
2007
Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes
2010
Structural biology of hepatitis C virus
2004
Revealing the world of RNA interference
2004 StandoutNatureNobel
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2005 StandoutNatureNobel
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Cyclin A‐Cys41 does not undergo cell cycle‐dependent degradation in Xenopus extracts
1992
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
The Domains Required to Direct Core Proteins of Hepatitis C Virus and GB Virus-B to Lipid Droplets Share Common Features with Plant Oleosin Proteins
2002
Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs
1994 StandoutNatureNobel
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
Hepatitis C Virus Core Protein Interacts with a Human DEAD Box Protein DDX3
1999
Cut2 proteolysis required for sister-chromatid separation in fission yeast
1996 StandoutNatureNobel
Independent inactivation of MPF and cytostatic factor (Mos) upon fertilization of Xenopus eggs
1991 StandoutNatureNobel
Functional hepatitis C virus envelope glycoproteins
2004
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
HCV and the hepatic lipid pathway as a potential treatment target
2011
Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly
2008
Mitosis in transition
1994
Antigenic relevance of F protein in chronic hepatitis C virus infection
2004
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex
1994 StandoutNobel
An in vitro model of hepatitis C virion production
2005
Genomic analysis of the host response to hepatitis C virus infection
2002
Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase.
1992
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
2007
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
Molecular Determinants for Subcellular Localization of Hepatitis C Virus Core Protein
2004
Antigenic relevance of F protein in chronic hepatitis C virus infection
2004
Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion
2015
Mitotic arrest caused by the amino terminus of Xenopus cyclin B2.
1993
The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.
1995 StandoutNobel
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
2010
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms
2009 StandoutNobel
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
2003
Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
2012
Both cyclin A delta 60 and B delta 97 are stable and arrest cells in M-phase, but only cyclin B delta 97 turns on cyclin destruction.
1991
Destruction of Xenopus cyclins A and B2, but not B1, requires binding to p34cdc2.
1994 StandoutNobel
Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity
2007
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins
2006
Memory Suppressor Genes: Inhibitory Constraints on the Storage of Long-Term Memory
1998 StandoutScienceNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.
1996 StandoutNobel
Hepatitis C Virus Core Protein Is a Dimeric Alpha-Helical Protein Exhibiting Membrane Protein Features
2005
Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex
2002
Hepatitis C Virus Core Protein Associates with Detergent-Resistant Membranes Distinct from Classical Plasma Membrane Rafts
2004 StandoutNobel
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus
2007
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
2006
Cyclin A-cdc2 kinase does not trigger but delays cyclin degradation in interphase extracts of amphibian eggs
1992
Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection
2003
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies
2011
Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs
2001
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Hepatitis C virus entry: potential receptors and their biological functions
2006
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
2010
Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes
2000
Genetic diversity and evolution of hepatitis C virus – 15 years on
2004
Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients
2006
Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion
2014
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
1994
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
The requirements for protein synthesis and degradation, and the control of destruction of cyclins A and B in the meiotic and mitotic cell cycles of the clam embryo.
1992 StandoutNobel
Proteome Analysis of Liver Cells Expressing a Full-Length Hepatitis C Virus (HCV) Replicon and Biopsy Specimens of Posttransplantation Liver from HCV-Infected Patients
2005
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo
2004
The Native Form and Maturation Process of Hepatitis C Virus Core Protein
1998
Neutralizing Antibody Response to Hepatitis C Virus
2011
The interaction of natural hepatitis C virus with human scavenger receptor SR‐BI/Cla1 is mediated by ApoB‐containing lipoproteins
2006
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein
2000
Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture
2007
Virus‐neutralizing antibodies to hepatitis C virus
2013
Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes
2010
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Degradation of the proto-oncogene product p39mos is not necessary for cyclin proteolysis and exit from meiotic metaphase: requirement for a Ca(2+)-calmodulin dependent event.
1991
Apolipoprotein C1 Association with Hepatitis C Virus
2008
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
2007
Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans
2015
Targeting of Hepatitis C Virus Core Protein to Mitochondria through a Novel C-Terminal Localization Motif
2004
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
2008
Components of a system that ligates cyclin to ubiquitin and their regulation by the protein kinase cdc2.
1994 StandoutNobel
Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture
2010
Identification of Residues in the Hepatitis C Virus Core Protein That Are Critical for Capsid Assembly in a Cell-Free System
2005
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Flaviviridae Replication Organelles: Oh, What a Tangled Web We Weave
2015
Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles
2006
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
2009
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
2010
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase.
1995 StandoutNobel
Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture
2002
Works of C Bréchot being referenced
Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon)
1994
Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C
1997
Mother-to-Child Transmission of Hepatitis C Virus Detected by Nested Polymerase Chain Reaction
1992
Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
1997
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets
1997
An okadaic acid-sensitive phosphatase negatively controls the cyclin degradation pathway in amphibian eggs.
1991
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
2002